Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Thermo Fisher Scientific Inc. TMO

Full chart Compare
Set alert

Price alert · TMO

All alert types
676.94 USD 0.00 (+0.00%)

At closeNov 6, 2026, 9:23 AM EST

665.91 -11.03 -1.63%

Pre-market · Nov 6, 9:23 AM ET

Day range unavailable

435.27 52-week range 712.17
YTD
+16.82%
1 year
+19.60%

Financial health

Altman Z-Score

4.11 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 3
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 2
  • P/B 2

Valuation

P/E 32.6×
FY 2016: 27.6×FY 2017: 33.7×FY 2018: 30.6×FY 2019: 35.2×FY 2020: 28.9×FY 2021: 34.0×FY 2022: 31.1×FY 2023: 34.2×FY 2024: 31.4×FY 2025: 32.6×
FY 2016 5y median 32.6× FY 2025
P/S 4.9×
FY 2016: 3.0×FY 2017: 3.6×FY 2018: 3.7×FY 2019: 5.1×FY 2020: 5.7×FY 2021: 6.7×FY 2022: 4.8×FY 2023: 4.8×FY 2024: 4.6×FY 2025: 4.9×
FY 2016 5y median 4.8× FY 2025
P/B 4.1×
FY 2016: 2.6×FY 2017: 3.0×FY 2018: 3.3×FY 2019: 4.4×FY 2020: 5.3×FY 2021: 6.4×FY 2022: 4.9×FY 2023: 4.4×FY 2024: 4.0×FY 2025: 4.1×
FY 2016 5y median 4.4× FY 2025
P/FCF 34.6×
FY 2016: 20.5×FY 2017: 21.4×FY 2018: 23.8×FY 2019: 32.1×FY 2020: 27.1×FY 2021: 37.4×FY 2022: 31.2×FY 2023: 29.6×FY 2024: 27.3×FY 2025: 34.6×
FY 2016 5y median 31.2× FY 2025
EV/EBITDA 21.6×
FY 2016: 16.8×FY 2017: 18.7×FY 2018: 17.2×FY 2019: 20.8×FY 2020: 19.5×FY 2021: 24.6×FY 2022: 20.4×FY 2023: 20.8×FY 2024: 19.3×FY 2025: 21.6×
FY 2016 5y median 20.8× FY 2025
EV/Sales 5.6×
FY 2016: 3.9×FY 2017: 4.5×FY 2018: 4.4×FY 2019: 5.7×FY 2020: 6.1×FY 2021: 7.5×FY 2022: 5.4×FY 2023: 5.4×FY 2024: 5.3×FY 2025: 5.6×
FY 2016 5y median 5.4× FY 2025
FCF Yield 2.9%
FY 2016: 4.9%FY 2017: 4.7%FY 2018: 4.2%FY 2019: 3.1%FY 2020: 3.7%FY 2021: 2.7%FY 2022: 3.2%FY 2023: 3.4%FY 2024: 3.7%FY 2025: 2.9%
FY 2016 5y median 3.2% FY 2025

Profitability

Gross Margin 40.9%
FY 2016: 47.0%FY 2017: 46.3%FY 2018: 45.1%FY 2019: 44.4%FY 2020: 49.7%FY 2021: 50.1%FY 2022: 42.3%FY 2023: 40.1%FY 2024: 41.3%FY 2025: 40.9%
FY 2016 5y median 41.3% FY 2025
Operating Margin 18.2%
FY 2016: 15.6%FY 2017: 15.6%FY 2018: 15.9%FY 2019: 16.7%FY 2020: 24.5%FY 2021: 26.3%FY 2022: 19.0%FY 2023: 17.4%FY 2024: 17.9%FY 2025: 18.2%
FY 2016 5y median 18.2% FY 2025
Net Margin 15.1%
FY 2016: 11.1%FY 2017: 10.6%FY 2018: 12.1%FY 2019: 14.5%FY 2020: 19.8%FY 2021: 19.7%FY 2022: 15.5%FY 2023: 14.0%FY 2024: 14.8%FY 2025: 15.1%
FY 2016 5y median 15.1% FY 2025
ROE 12.6%
FY 2016: 9.4%FY 2017: 8.8%FY 2018: 10.7%FY 2019: 12.5%FY 2020: 18.5%FY 2021: 18.9%FY 2022: 15.8%FY 2023: 12.8%FY 2024: 12.8%FY 2025: 12.6%
FY 2016 5y median 12.8% FY 2025
ROIC 7.6%
FY 2016: 6.6%FY 2017: 5.8%FY 2018: 6.8%FY 2019: 7.3%FY 2020: 11.3%FY 2021: 10.7%FY 2022: 9.0%FY 2023: 8.0%FY 2024: 8.0%FY 2025: 7.6%
FY 2016 5y median 8.0% FY 2025
ROA 6.1%
FY 2016: 4.4%FY 2017: 3.9%FY 2018: 5.2%FY 2019: 6.3%FY 2020: 9.2%FY 2021: 8.1%FY 2022: 7.2%FY 2023: 6.1%FY 2024: 6.5%FY 2025: 6.1%
FY 2016 5y median 6.5% FY 2025

Growth (YoY)

Revenue 3.9%
FY 2016: 7.7%FY 2017: 14.5%FY 2018: 16.4%FY 2019: 4.9%FY 2020: 26.1%FY 2021: 21.7%FY 2022: 14.5%FY 2023: -4.6%FY 2024: 0.1%FY 2025: 3.9%
FY 2016 FY 2025
Operating Income 5.8%
FY 2016: 14.6%FY 2017: 14.3%FY 2018: 18.5%FY 2019: 10.0%FY 2020: 85.4%FY 2021: 30.7%FY 2022: -17.4%FY 2023: -12.7%FY 2024: 2.9%FY 2025: 5.8%
FY 2016 FY 2025
EPS (diluted) 7.3%
FY 2016: 3.5%FY 2017: 9.8%FY 2018: 29.5%FY 2019: 26.7%FY 2020: 74.3%FY 2021: 21.8%FY 2022: -9.4%FY 2023: -12.4%FY 2024: 7.0%FY 2025: 7.3%
FY 2016 FY 2025
Free Cash Flow -13.4%
FY 2016: 13.3%FY 2017: 29.0%FY 2018: 8.2%FY 2019: 6.9%FY 2020: 68.4%FY 2021: 3.0%FY 2022: -1.6%FY 2023: 0.2%FY 2024: 4.9%FY 2025: -13.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 1.4×FY 2017: 1.3×FY 2018: 1.7×FY 2019: 1.9×FY 2020: 2.1×FY 2021: 1.5×FY 2022: 1.5×FY 2023: 1.8×FY 2024: 1.7×FY 2025: 1.9×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 1.5×
FY 2016: 1.0×FY 2017: 0.9×FY 2018: 1.2×FY 2019: 1.4×FY 2020: 1.7×FY 2021: 1.1×FY 2022: 1.2×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.5×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 0.7×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 0.7×FY 2021: 0.9×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 3.7×FY 2017: 3.9×FY 2018: 2.7×FY 2019: 2.3×FY 2020: 1.2×FY 2021: 2.7×FY 2022: 2.3×FY 2023: 2.5×FY 2024: 2.4×FY 2025: 2.6×
FY 2016 5y median 2.5× FY 2025
Interest Coverage 5.7×
FY 2016: 6.1×FY 2017: 5.5×FY 2018: 5.8×FY 2019: 6.3×FY 2020: 14.3×FY 2021: 19.3×FY 2022: 11.7×FY 2023: 5.0×FY 2024: 4.6×FY 2025: 5.7×
FY 2016 5y median 5.7× FY 2025

Dividends

Dividend Yield 0.3%
FY 2016: 0.4%FY 2017: 0.3%FY 2018: 0.3%FY 2019: 0.2%FY 2020: 0.2%FY 2021: 0.2%FY 2022: 0.2%FY 2023: 0.3%FY 2024: 0.3%FY 2025: 0.3%
FY 2016 5y median 0.3% FY 2025
Payout Ratio 9.4%
FY 2016: 11.8%FY 2017: 10.7%FY 2018: 9.1%FY 2019: 8.0%FY 2020: 5.3%FY 2021: 5.1%FY 2022: 6.5%FY 2023: 8.7%FY 2024: 9.2%FY 2025: 9.4%
FY 2016 5y median 8.7% FY 2025

Annual · latest fiscal year ends 2025-12-31